‹ Screener

Insight Molecular Diagnostics Inc.

IMDX · In Vitro & In Vivo Diagnostic Substances · 32.3M shares · +54%/yr ↑ dilution · EDGAR filings ↗

Reference price $3.64 · est. market cap ~$118M — last insider purchase, 2026-04-27 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

D42

Micro-cap molecular-diagnostics company with deep losses and thin liquidity, growing.

Strengths

Risks

Notable findings

Quarterly revenue

2025-06-30 · $518K2025-09-30 · $260K2025-12-31 · $1M2026-03-31 · $32K

Last 4 quarters · from SEC filings.

Key metrics

Gross margin
56.7%
Operating margin
-1260.8%
Net margin
-1238.5%
Return on equity
159.6%
Return on assets
-195.0%
Revenue growth (QoQ)
-97.2%
Current ratio
1.3×
Free cash flow
-$25M
EBITDA
-$49M
Tangible book value
-$31M
Cash & investments
$12M
Cash runway
2q
Stock comp / revenue
54.7%

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-06-11Last Andrew J.Grant27K
2026-06-11SILVERMAN LOUGrant27K
2026-06-11Arno AndrewGrant32K
2026-04-27BROADWOOD PARTNERS, L.P.Buy0
2026-04-27BROADWOOD PARTNERS, L.P.Buy251K$3.64
2026-04-24BROADWOOD PARTNERS, L.P.Buy39K$3.53
2026-04-24BROADWOOD PARTNERS, L.P.Buy0
2026-04-23BROADWOOD PARTNERS, L.P.Buy280K$3.50
2026-04-23BROADWOOD PARTNERS, L.P.Buy0
2026-04-20BROADWOOD PARTNERS, L.P.Buy41K$3.88
2026-04-20BROADWOOD PARTNERS, L.P.Buy0
2026-04-17BROADWOOD PARTNERS, L.P.Buy40K$3.57
2026-04-17BROADWOOD PARTNERS, L.P.Buy0
2026-04-16BROADWOOD PARTNERS, L.P.Buy0
2026-04-16BROADWOOD PARTNERS, L.P.Buy102K$3.45
2026-03-26James Andrea S.Option exercise28K
2026-03-26James Andrea S.Tax withheld11K$4.11
2026-03-26Liu James YangOption exercise6.3K
2026-03-26Liu James YangTax withheld2.6K$4.11
2026-03-26Riggs JoshOption exercise47K
2026-03-26Riggs JoshTax withheld12K$4.11
2026-02-10BROADWOOD PARTNERS, L.P.Buy522K$5.75
2026-02-10BROADWOOD PARTNERS, L.P.Buy0
2025-10-31James Andrea S.Tax withheld12K$6.01
2025-10-31James Andrea S.Option exercise50K
2025-10-31James Andrea S.Option exercise50K
2025-07-01Arno AndrewGrant55K
2025-07-01SILVERMAN LOUGrant35K
2025-07-01Last Andrew J.Grant35K
2025-02-07James Andrea S.Buy98K$2.05
2025-02-07SMITH PATRICK WBuy1.1M$2.05
2025-02-07SMITH PATRICK WOther386K$2.05
2025-02-06BROADWOOD PARTNERS, L.P.Buy0
2025-02-06BROADWOOD PARTNERS, L.P.Buy660K$2.05
2025-02-06BROADWOOD PARTNERS, L.P.Buy4.5M$2.05
2025-02-06BROADWOOD PARTNERS, L.P.Buy0
2025-02-04SMITH PATRICK WBuy25$2.02
2025-01-31SMITH PATRICK WBuy890$2.01
2025-01-30SMITH PATRICK WBuy318$2.01
2025-01-29SMITH PATRICK WBuy3.9K$2.01
2025-01-14SMITH PATRICK WBuy100$2.08
2025-01-14SMITH PATRICK WBuy10K$2.15
2025-01-13SMITH PATRICK WBuy5.7K$2.08

All non-derivative Form 4 activity (SEC), newest first.

Notable events (8-K)

DateItems
2026-06-17Exec/director changeShareholder voteExhibitsfiling ↗
2026-05-13Otherfiling ↗
2026-05-13ResultsExhibitsfiling ↗
2026-04-30OtherExhibitsfiling ↗
2026-03-26ResultsExhibitsfiling ↗
2026-02-26Material agreementExhibitsfiling ↗
2026-02-12Material agreementOtherExhibitsfiling ↗
2026-02-11Reg FDExhibitsfiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-06-172026-06-110001493152-26-029078 ↗
8-K2026-05-132026-05-130001493152-26-022721 ↗
10-Q2026-05-132026-03-310001642380-26-000008 ↗
8-K/A2026-05-132026-02-200001493152-26-022708 ↗
8-K2026-04-302026-04-300001493152-26-020461 ↗
8-K2026-03-262026-03-260001493152-26-012915 ↗
10-K2026-03-262025-12-310001642380-26-000004 ↗
8-K2026-02-262026-02-200001493152-26-008169 ↗
8-K2026-02-122026-02-100001493152-26-006473 ↗
8-K2026-02-112026-02-110001493152-26-006117 ↗
8-K2025-11-102025-11-100001493152-25-021513 ↗
10-Q2025-11-102025-09-300001193125-25-274266 ↗